분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2017-09-01 09:44:52 , Hit : 688
 First CAR T-Cell Therapy Approved in U.S.

The Scientist »
The Nutshell

http://www.the-scientist.com/?articles.view/articleNo/50231/title/First-CAR-T-Cell-Therapy-Approved-in-U-S-/&utm_campaign=NEWSLETTER_TS_The-Scientist-Daily_2016&utm_source=hs_email&utm_medium=email&utm_content=55843454&_hsenc=p2ANqtz-9X__FTJkvm1fbmiaGryJQJBBTqBqgFAYu4aL3cWVIz1oRoLd2CUGqUWRLFb7t17z8OXYx1oIdhYo4QTd_VIwIZArL3EA&_hsmi=55843454/


The genetically modified blood cells will be used for patients with a type of acute lymphoblastic leukemia, when other treatments fail.

By Shawna Williams | August 30, 2017


Each patient’s T-cells will be harvested from the body and genetically programmed to target leukemia cells.


The US Food and Drug Administration (FDA) announced today (August 30) that it has approved the first therapy involving chimeric antigen receptor (CAR) T cells for clinical use. Each dose of Novartis’s drug, Kymriah, will consist of a patient’s own white blood cells, harvested from the body and genetically programmed to seek an antigen on the surface of leukemia cells.

“We’re entering a new frontier in medical innovation with the ability to reprogram a patient’s own cells to attack a deadly cancer,” says FDA Commissioner Scott Gottlieb in a statement. “New technologies such as gene and cell therapies hold out the potential to transform medicine and create an inflection point in our ability to treat and even cure many intractable illnesses.”

Kymriah is approved for patients 25 years old and younger who have B-cell acute lymphoblastic leukemia, and whose disease has relapsed at least twice or is still detectable after other treatment. In a clinical trial, the therapy left 83 percent of such patients cancer-free after three months. STAT notes that only a few hundred patients per year may be eligible for the cell therapy. Priced at $475,000, it will be offered at just 32 sites around the country.

See “The CAR T-Cell Race”

Despite the limited use of Kymriah, the approval ushers in “a new approach to the treatment of cancer and other serious and life-threatening diseases,” FDA says. Business Insider reports that at an FDA meeting last month, oncologist Tim Cripe of Nationwide Children’s Hospital called Kymriah “the most exciting thing I’ve seen in my lifetime.”







1207   CRISPR Used in Human Embryos to Probe Gene Function  이성욱 2017/09/22 582
1206   Alcoholism Gene Therapy Shows Promise  이성욱 2017/09/20 581
1205   DNA Construction  이성욱 2017/09/15 656
1204   Cargo-Sorting DNA Robots  이성욱 2017/09/15 1137
1203   From Startups to Moguls] CRISPR 유전자가위 없이 편집한다? Homology Medicines  이성욱 2017/09/11 603
1202   Outsourcing Gene Editing to the Public-Online Game Challenges Players to Design CRISPR On/Off Switch  이성욱 2017/09/05 721
1201   Scientists Doubt Results of CRISPR’d Embryos  이성욱 2017/09/02 538
1200   Scientists Look to Epigenetics to Thwart Viruses  이성욱 2017/09/02 707
  First CAR T-Cell Therapy Approved in U.S.  이성욱 2017/09/01 688
1198   UPDATED: FDA ushers in a new era in cancer treatment with ‘historic’ CAR-T approval for Novartis  이성욱 2017/08/31 694
1197   “유전자 치료 법률 금지 한국 유일” vs “생명체 설계도 바꾸는 건 문제”  이성욱 2017/08/28 728
1196   Cancer Onset May Be Caused by Immune System Fighting Viruses  이성욱 2017/08/25 715
1195   유전자 가위로 바이러스 제거한 '청정 돼지' 나왔다  이성욱 2017/08/24 759
1194   CRISPR Corrects RNA-based Disease Defects  이성욱 2017/08/14 733
1193   Uncovering Functions of Circular RNAs  이성욱 2017/08/14 719
1192   First In Vivo Function Found for Animal Circular RNA  이성욱 2017/08/14 751
1191   Gene Study Based on RNA Interference May Lead to New Liver Cancer Therapies  이성욱 2017/08/14 808
1190   Resistance to HIV Engineered Via CRISPR  이성욱 2017/08/07 712
1189   [바이오토픽] 드디어 올 것이 왔다: CRISPR, 생존가능 인간배아의 질병초래 유전자 교정 성공  이성욱 2017/08/03 728
1188   Engineered Human Liver Tissue Grows in Mice  이성욱 2017/07/25 778

[1][2][3] 4 [5][6][7][8][9][10]..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN